Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Bal

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
British Journal of Haematology|November 30, 2023
Bridging treatment prior to chimeric antigen receptor T-cell therapy in multiple myelomaSusan Bal, Luciano J Costa
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|October 3, 2014
Myocardial perfusion imaging determination using an appropriate use smartphone applicationAshish Mahajan, Susan Bal, Harvey Hahn
Frontiers in Oncology|March 13, 2023
Editorial: Advances in the understanding of pathogenesis, diagnosis, and therapy of light chain amyloidosisDivaya Bhutani, Susan Bal, Samuel Rubinstein
JAMA Oncology|February 18, 2021
Caution With Routine Use of Daratumumab for Newly Diagnosed High-Risk Multiple Myeloma-ReplySmith Giri, Susan Bal, Luciano J Costa
Journal of Surgical Oncology|July 6, 2016
The impending financial healthcare burden and ethical dilemma of systemic therapy in metastatic cancerMuhammad Kashif Riaz, Susan Bal, Trisha Wise-Draper
Nuclear Medicine Communications|November 11, 2010
Long-term outcome of lobar ablation versus completion thyroidectomy in differentiated thyroid cancerAmburanjan Santra, Susan Bal, Sagar Mahargan, et al.
Cancer Immunology Research|August 3, 2019
Lessons Learned from Checkpoint Blockade Targeting PD-1 in Multiple MyelomaAlexander M Lesokhin, Susan Bal, Ashraf Z Badros
Annals of Hematology|February 9, 2022
Revisiting the impact of immunoglobulin isotypes in multiple myelomaSusan Bal, Smith Giri, Kelly N Godby, et al.
British Journal of Haematology|August 1, 2019
Challenges and opportunities in the assessment of measurable residual disease in multiple myelomaSusan Bal, Allison Weaver, Robert F Cornell, et al.
British Journal of Haematology|June 24, 2021
Impact of t(11;14) as a sole and concomitant abnormality on outcomes in multiple myelomaSusan Bal, Smith Giri, Kelly N Godby, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
British Journal of Haematology|November 30, 2023
Bridging treatment prior to chimeric antigen receptor T-cell therapy in multiple myelomaSusan Bal, Luciano J Costa
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|October 3, 2014
Myocardial perfusion imaging determination using an appropriate use smartphone applicationAshish Mahajan, Susan Bal, Harvey Hahn
Frontiers in Oncology|March 13, 2023
Editorial: Advances in the understanding of pathogenesis, diagnosis, and therapy of light chain amyloidosisDivaya Bhutani, Susan Bal, Samuel Rubinstein
JAMA Oncology|February 18, 2021
Caution With Routine Use of Daratumumab for Newly Diagnosed High-Risk Multiple Myeloma-ReplySmith Giri, Susan Bal, Luciano J Costa
Journal of Surgical Oncology|July 6, 2016
The impending financial healthcare burden and ethical dilemma of systemic therapy in metastatic cancerMuhammad Kashif Riaz, Susan Bal, Trisha Wise-Draper
Nuclear Medicine Communications|November 11, 2010
Long-term outcome of lobar ablation versus completion thyroidectomy in differentiated thyroid cancerAmburanjan Santra, Susan Bal, Sagar Mahargan, et al.
Cancer Immunology Research|August 3, 2019
Lessons Learned from Checkpoint Blockade Targeting PD-1 in Multiple MyelomaAlexander M Lesokhin, Susan Bal, Ashraf Z Badros
Annals of Hematology|February 9, 2022
Revisiting the impact of immunoglobulin isotypes in multiple myelomaSusan Bal, Smith Giri, Kelly N Godby, et al.
British Journal of Haematology|August 1, 2019
Challenges and opportunities in the assessment of measurable residual disease in multiple myelomaSusan Bal, Allison Weaver, Robert F Cornell, et al.
British Journal of Haematology|June 24, 2021
Impact of t(11;14) as a sole and concomitant abnormality on outcomes in multiple myelomaSusan Bal, Smith Giri, Kelly N Godby, et al.
Pageof 7